Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 27.77% is 81% above its 5-year average of 15.38%, near the high end of its 5-year range (-16.97%–27.77%).
As of the fiscal period ended Tuesday, March 31, 2026. 17.15% above its 12-month average of 23.71%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
27.77%
OPERATING MARGIN AVG TTM
23.71%
OPERATING MARGIN AVG 3Y
20.70%
OPERATING MARGIN AVG 5Y
17.00%
OPERATING MARGIN AVG 10Y
16.73%
OPERATING MARGIN AVG 15Y
17.87%
OPERATING MARGIN AVG 20Y
22.08%
CURRENT VS TTM AVG
+17.15%
CURRENT VS 3Y AVG
+34.18%
CURRENT VS 5Y AVG
+63.35%
CURRENT VS 10Y AVG
+65.97%
CURRENT VS 15Y AVG
+55.39%
CURRENT VS 20Y AVG
+25.79%
SECTOR MEDIAN · HEALTHCARE
15.01%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+85.03%
vs the sector median at left
AstraZeneca PLC
Market Cap
$131.47B
Operating Margin
27.77%
TTM Avg
23.71%
3Y Avg
20.70%
5Y Avg
17.00%
Market Cap
$133.41B
Operating Margin
28.27%
TTM Avg
23.17%
3Y Avg
21.31%
5Y Avg
19.39%
Market Cap
$137.13B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$124.86B
Operating Margin
22.03%
TTM Avg
20.93%
3Y Avg
20.75%
5Y Avg
21.02%
Market Cap
$124.82B
Operating Margin
31.28%
TTM Avg
28.70%
3Y Avg
26.89%
5Y Avg
27.25%
Market Cap
$121.09B
Operating Margin
38.97%
TTM Avg
18.66%
3Y Avg
31.09%
5Y Avg
34.52%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $131.47B | 27.77% | 23.71% | 20.70% | 17.00% |
| CVS Health Corp. (CVS)vs › | $133.25B | 1.46% | 2.43% | 2.79% | 3.48% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.41B | 28.27% | 23.17% | 21.31% | 19.39% |
| Danaher Corporation (DHR)vs › | $137.13B | 20.42% | 21.31% | 23.25% | 23.28% |
| Stryker Corporation (SYK)vs › | $124.86B | 22.03% | 20.93% | 20.75% | 21.02% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 31.28% | 28.70% | 26.89% | 27.25% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 38.97% | 18.66% | 31.09% | 34.52% |
| Pfizer Inc. (PFE)vs › | $142.54B | 23.45% | 25.29% | 24.23% | 24.05% |
| Medtronic plc (MDT)vs › | $109.30B | 17.78% | 17.77% | 17.25% | 17.00% |
| GSK plc (GSK)vs › | $103.56B | 25.65% | 19.17% | 20.63% | 20.79% |
Gross Margin
81.7%
Operating Margin
27.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 27.77% |
| 2025-12-31 | 19.21% |
| 2025-09-30 | 23.59% |
| 2025-06-30 | 24.27% |
| 2025-03-30 | 27.04% |
| 2024-12-31 | 13.67% |
| 2024-09-30 | 15.53% |
| 2024-06-30 | 21.22% |
| 2024-03-31 | 24.57% |
| 2023-12-31 | 10.26% |
| 2023-09-30 | 17.00% |
| 2023-06-30 | 21.51% |
| 2023-03-31 | 23.43% |
| 2022-12-31 | 9.76% |
| 2022-09-30 | 11.34% |
| 2022-06-30 | 5.00% |
| 2022-03-31 | 7.71% |
| 2021-12-31 | -2.43% |
| 2021-09-30 | -16.97% |
| 2021-06-30 | 13.71% |
| 2021-03-31 | 25.89% |
| 2020-12-31 | 20.07% |
| 2020-09-30 | 17.80% |
| 2020-06-30 | 20.46% |
| 2020-03-31 | 19.20% |
| 2019-12-31 | 8.66% |
| 2019-09-30 | 11.82% |
| 2019-06-30 | 8.47% |
| 2019-03-31 | 19.98% |
| 2018-12-31 | 16.78% |
| 2018-09-30 | 15.94% |
| 2018-06-30 | 14.80% |
| 2018-03-31 | 13.44% |
| 2017-12-31 | 11.87% |
| 2017-09-30 | 18.44% |
| 2017-06-30 | 18.31% |
| 2017-03-31 | 16.97% |
| 2016-12-31 | 45.35% |
| 2016-09-30 | 18.04% |
| 2016-06-30 | 5.41% |
| 2016-03-31 | 16.97% |
| 2015-12-31 | 17.00% |
| 2015-09-30 | 19.68% |
| 2015-06-30 | 14.63% |
| 2015-03-31 | 15.40% |
| 2014-12-31 | -5.22% |
| 2014-09-30 | 8.19% |
| 2014-06-30 | 16.40% |
| 2014-03-31 | 12.94% |
| 2013-12-31 | -8.64% |
| 2013-09-30 | 27.30% |
| 2013-06-30 | 19.26% |
| 2013-03-31 | 21.88% |
| 2012-12-31 | 26.97% |
| 2012-09-30 | 32.27% |
| 2012-06-30 | 28.05% |
| 2012-03-31 | 29.39% |
| 2011-12-31 | 25.03% |
| 2011-09-30 | 51.89% |
| 2011-06-30 | 35.17% |
| 2011-03-31 | 41.02% |
| 2010-12-31 | 27.98% |
| 2010-09-30 | 30.46% |
| 2010-06-30 | 37.10% |
| 2010-03-31 | 42.48% |
| 2009-12-31 | 25.99% |
| 2009-09-30 | 39.07% |
| 2009-06-30 | 35.83% |
| 2009-03-31 | 41.07% |
| 2008-12-31 | 23.09% |
| 2008-09-30 | 32.44% |
| 2008-06-30 | 31.08% |
| 2008-03-31 | 29.40% |
| 2007-12-31 | 23.61% |
| 2007-09-30 | 28.28% |
| 2007-06-30 | 27.13% |
| 2007-03-31 | 31.15% |
| 2006-12-31 | 28.00% |
| 2006-09-30 | 32.32% |
| 2006-06-30 | 32.17% |
| 2006-03-31 | 31.97% |
| 2005-12-31 | 26.03% |
| 2005-09-30 | 29.28% |
| 2005-06-30 | 28.02% |
| 2005-03-31 | 25.30% |
| 2004-12-31 | -51.06% |
| 2004-09-30 | 22.26% |
| 2004-06-30 | 19.89% |
| 2004-03-31 | 20.73% |
| 2003-12-31 | 17.42% |
| 2003-09-30 | 22.92% |
| 2003-06-30 | 20.05% |
| 2003-03-31 | 26.86% |
| 2002-12-31 | 15.50% |
| 2002-09-30 | 21.08% |
| 2002-06-30 | 24.68% |
